ClariVest Asset Management’s Array Biopharma Inc ARRY Stock Holding History

ClariVest Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-298,838	Closed	-$7.29M	–	799
2019 Q1	$7.29M	Buy	298,838 +71,760	+32%	+$1.49M	0.15%	140
2018 Q4	$3.23M	Buy	227,078 +48,479	+27%	+$735K	0.07%	227
2018 Q3	$2.71M	Sell	178,599 -2,158	-1%	-$33.1K	0.05%	270
2018 Q2	$3.03M	Sell	180,757 -19,824	-10%	-$315K	0.05%	281
2018 Q1	$3.27M	Buy	+200,581	New	+$3.21M	0.06%	254
2016 Q2	–	Sell	-186,123	Closed	-$550K	–	712
2016 Q1	$550K	Buy	186,123 +7,375	+4%	+$22.1K	0.02%	351
2015 Q4	$753K	Buy	+178,748	New	+$816K	0.02%	317

Other funds holding ARRY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ClariVest Asset Management's ARRY Position: Q2 2019 in Review

ClariVest Asset Management sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 298,838 shares — an estimated $7.29M sold.

ClariVest Asset Management first reported a position in ARRY in Q4 2015 and held it in 7 quarters. The position peaked at $7.29M in Q1 2019. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

ClariVest Asset Management reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
ClariVest Asset Management sold 298,838 Array Biopharma Inc shares in Q2 2019, an estimated $7.29M.
ClariVest Asset Management first reported a position in Array Biopharma Inc in Q4 2015 and held it in 7 quarters.
ClariVest Asset Management's Array Biopharma Inc position peaked at $7.29M in Q1 2019.
318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on ClariVest Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.